Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery

NCT00873002 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Dose Limiting Toxicity

Conditions

Liver Cancer

Interventions

DRUG: panobinostat
DRUG: sorafenib tosylate

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]